Global Corneal Transplant Market
Market Size in USD Billion
CAGR :
% 
 Forecast Period |
2024 –2031 |
 Market Size (Base Year) |
USD 436.38 Million |
 Market Size (Forecast Year) |
USD 698.94 Million |
 CAGR |
% |
| Major Markets Players |
Global Corneal Transplant Market, By Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artificial Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others) - Industry Trends and Forecast to 2031
Corneal Transplant Market Analysis and Size
The global corneal implants market is driven by several factors, including the increasing prevalence of corneal diseases, a growing aging population, advances in technology, increasing demand for minimally invasive procedures, rising awareness of corneal transplantation, government initiatives and funding, increasing adoption of hybrid and toric lenses, growing popularity of cross-linking procedures, expanding indications for corneal implants, and a competitive landscape that fosters innovation. These factors are collectively driving the demand for corneal implants, particularly in developed countries, as patients seek effective treatments for vision disorders and conditions such as keratoconus, Fuchs' dystrophy, and pseudophakic bullous keratopathy.
Data Bridge Market Research analyzes that the global corneal transplant market is expected to reach USD 698.94 million by 2031 from USD 436.38 million in 2023, growing with a CAGR of 6.1% in the forecast period of 2024 to 2031.
|
Report Metric |
Details |
|
Forecast Period |
2024 to 2031 |
|
Base Year |
2023 |
|
Historic Years |
2022 (Customizable 2016-2021) |
|
Quantitative Units |
Revenue in USD Million |
|
Segments Covered |
Procedure Type (Endothelial Keratoplasty, Penetrating Keratoplasty, Anterior Lamellar Keratoplasty (ALK), Corneal Limbal Stem Cell Transplant, Artificial Cornea Transplant, and Others), Type (Human Cornea and Synthetic), Donor Type (Autograft and Allograft), Graft Type (Partial Thickness Grafts (Lamellar) and Full Thickness Grafts (Penetrating)), Surgery Type (Conventional Surgery, Laser-Assisted Surgery), Indication (Fuch's Endothelial Dystrophy, Infectious Keratitis, Bullous Keratopathy, Keratoconus, Regraft Procedures, Corneal Scarring, Corneal Ulcers, and Others), Gender (Female and Male), Age Group (Geriatric, Adult, and Pediatric), End User (Hospitals, Eye Clinics, Ambulatory Surgical Centers, Academic & Research Institutes, and Others) |
|
Countries Covered |
U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Denmark, Norway, Sweden, Poland, Rest of Europe, Brazil, Argentina, Rest of South America, China, India, Japan, Australia, South Korea, Singapore, Philippines, Malaysia, Indonesia, Thailand and Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa |
|
Market Players Covered |
ZEISS Group (Carl Zeiss Meditec AG.), Alcon, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., among others. |
Market Definition
The corneal transplant market refers to the medical field focused on surgical procedures that replace damaged or diseased corneas with healthy donor tissue. Corneal transplants, also known as keratoplasty, are performed to restore vision in patients suffering from conditions such as keratoconus, corneal scarring, infections, or corneal endothelial dysfunction. The market encompasses various types of transplant procedures, including penetrating keratoplasty (full-thickness corneal transplant) and endothelial keratoplasty (partial-thickness transplant), and is supported by advancements in surgical techniques, availability of donor tissues, and improved postoperative care. As eye disorders become more prevalent globally, and with technological innovations enhancing the success rate of surgeries, the corneal transplant market continues to grow, addressing the rising demand for vision restoration.
Global Corneal Transplant Market Dynamics:
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail as below:
Drivers
- Increasing Prevalence of Eye Diseases
The increasing prevalence of eye diseases is a significant driver in the global corneal transplant market, as conditions like keratoconus, Fuchs' endothelial dystrophy, and corneal scarring due to infections or trauma are becoming more common. These diseases can lead to severe vision impairment or blindness, prompting a growing demand for corneal transplants as a restorative treatment. The rise in eye disorders is often linked to factors such as aging populations, higher rates of diabetes, and increased exposure to environmental pollutants and UV radiation, which can damage the cornea. Also, advancements in diagnostic techniques are leading to earlier detection of these diseases, allowing for timely interventions, including corneal transplantation. Furthermore, greater awareness of corneal health and the availability of improved surgical techniques, such as Descemet's Membrane Endothelial Keratoplasty (DMEK) and Descemet's Stripping Automated Endothelial Keratoplasty (DSAEK), are contributing to the growing acceptance of corneal transplants. As the burden of eye diseases continues to grow worldwide, the need for effective solutions like corneal transplants is expected to rise, fueling market growth.
For instance,
- In June 2023, according to the article published in NCBI, a study was conducted to investigate the prevalence of keratoconus in a large German cohort and to evaluate possible associated factors. Keratoconus appears to be a rare corneal disease with a prevalence previously estimated at 1:2000. However, in recent relatively small studies, a higher prevalence was found. Prevalence is reported from 1: 6000 for US citizens, 1:1000 for Israeli adolescents, up to 1:20 for Saudi-Arabian Children. Newer studies detected prevalence estimates of 1:191 in New Zealand high school students. A prevalence of up to 1:84 was detected for young Australian adults. The prevalence of keratoconus treatment in the German population is approximately tenfold higher than previously reported in the literature using the latest technologies, namely Scheimpflug imaging, which act as a driver in the growth of the market.
Rising Geriatric Population
The rising geriatric population is a key driver in the global corneal transplant market, as older adults are more susceptible to various eye conditions that can lead to corneal damage and the need for transplants. Age-related eye diseases, such as Fuchs' endothelial dystrophy, bullous keratopathy, and other degenerative corneal disorders, become more prevalent with advancing age, significantly increasing the demand for corneal transplants. Also, older adults are more likely to experience complications from cataract surgery or develop chronic conditions like diabetes, which can further contribute to corneal deterioration. As the global population ages, the number of individuals requiring corneal transplants is expected to rise, particularly in regions with rapidly aging demographics. This trend is further fueled by increased awareness about the availability and success rates of corneal transplants, as well as advancements in surgical techniques that offer better outcomes and faster recovery times for older patients. As a result, the growing geriatric population is a major factor driving the expansion of the global corneal transplant market, highlighting the need for accessible and effective treatment options for age-related corneal diseases.
Opportunity
- Rise in Healthcare Infrastructure
The rise in healthcare infrastructure offers significant opportunities for the global corneal transplant market by expanding access to transplant services. Enhanced infrastructure leads to the establishment of more hospitals and specialized clinics, making corneal transplants more accessible to a broader population. Improved facilities in underserved or rural areas ensure that patients who previously had limited access to specialized eye care can now receive essential transplant services.
Modernized healthcare facilities are equipped with advanced surgical technologies and diagnostic tools, which directly improve the success rates of corneal transplants and minimize complications. Specialized centers within these advanced systems provide focused expertise and resources, further enhancing surgical outcomes and patient care. The increased capacity of these facilities also supports a higher volume of transplant procedures, effectively addressing patient demand and reducing waiting times.
For instance,
- In April 2024, according to the article ‘The Rise of Hospital Infrastructure & Modernization Updates,’ the U.S. boasts of a robust healthcare infrastructure consisting of over 6,000 hospitals and thousands of small clinics, offering more than a million hospital beds to patients. This infrastructure encompasses a variety of essential elements, such as advanced research labs, cutting-edge technology, and a wide range of medical equipment. Moreover, the federal government has been providing funds for the continuous modernization of the country’s healthcare infrastructure
- In August 2023, according to JLL India, India has been welcoming more investments and innovation to deal with future life-threatening diseases and pandemics that, in turn, help in growing the country’s healthcare and life sciences sector
Restraint/Challenge
- The High Cost of Corneal Transplant Surgery
The high cost of corneal transplant surgery acts as a significant restraint on the growth of the global corneal transplant market by limiting patient access and affordability, particularly in low- and middle-income countries. Corneal transplant procedures, including traditional Penetrating Keratoplasty (PK) and advanced techniques like Descemet’s Membrane Endothelial Keratoplasty (DMEK) or Descemet’s Stripping Automated Endothelial Keratoplasty (DSAEK), often involve substantial expenses not only for the surgical procedure itself but also for the associated costs of preoperative assessments, postoperative care, medications, and follow-up visits. Also, the cost of obtaining donor corneas, whether through eye banks or commercial sources, further contributes to the financial burden. In many regions, particularly those with limited healthcare infrastructure, these costs are exacerbated by a lack of insurance coverage or inadequate reimbursement policies, making corneal transplants financially inaccessible to a large portion of the population. Furthermore, the need for specialized surgical expertise and advanced equipment increases the overall expense, thereby restricting the availability of these procedures to well-equipped medical centers in urban areas. Consequently, the high costs associated with corneal transplant surgery hinder market growth by reducing the potential patient pool, especially in underserved regions where the burden of corneal diseases is often most significant and access to affordable healthcare is limited.
For instance,
- According to the data published by Indiaorgantransplant.com, The average cost of eye transplant surgery in India is around Rs.2, 10,000 (USD 2,600) to Rs.2, 60,000 (USD 3,200). The cost depends on several factors, such as the type of procedure, surgeon's fees, hospital charges, and other associated costs. Also, the average cost of a transplant in India is much higher than any other treatment, which becomes a major factor in opting against transplant surgery and acts as a restraint in the growth of the market
Recent Developments
- In January 2024, Carl Zeiss India's Medical Technology Division showcased Cataract and Refractive Workflow at Phaco Festival by Nethradhama Super Speciality, Bengaluru. At the Phaco Festival, the spotlight shined on ZEISS's transformative impact on the Cataract and Corneal Refractive Workflows
- In June 2024, CorneaGen today announces the commercial launch of Corneal Tissue Addition for Keratoplasty (CTAK), an innovative and extremely effective solution to corneal contouring for keratoconic eyes. Developed by CorneaGen in partnership with CTAK LLC and Ziemer, CTAK provides patient ready, gamma-irradiated sterile, non-immunogenic corneal tissue segments, laser cut and customized to patients’ specific cone severity and location
- In January 2024, Seattle-based CorneaGen is excited to announce an expansion of their eye recovery services throughout northern and southern California. Through this expansion of service, CorneaGen will now provide both eye recovery and processing services of donor tissue for facilities throughout the state, resulting in an even better experience for the patients, families, and staff of their California partner facilities
- In August 2024, ZEISS extends its global refractive industry momentum with more than 10 million eyes treated with ZEISS SMILE and ZEISS SMILE pro; ZEISS announces first treatment in the CE market for hyperopia with lenticule extraction using ZEISS SMILE pro technology
Global Corneal Transplant Market Scope
The global corneal transplant market is segmented into eight notable segments based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the differences in your target markets.
Procedure Type
- Endothelial Keratoplasty
- Penetrating Keratoplasty
- Anterior Lamellar Keratoplasty (ALK)
- Corneal Limbal Stem Cell Transplant
- Artificial Cornea Transplant
- Others
On the basis of procedure type, the market is segmented into endothelial keratoplasty, penetrating keratoplasty, Anterior Lamellar Keratoplasty (ALK), corneal limbal stem cell transplant, artificial cornea transplant and others.
Type
- Human Cornea
- Synthetic
On the basis of type, the market is segmented into human cornea and synthetic.
Donor Type
- Allograft
- Autograft
On the basis of donor type, the market is segmented into allograft and autograft.
Graft Type
- Partial Thickness Grafts (Lamellar)
- Full Thickness Grafts (Penetrating)
On the basis of graft type, the market is segmented into partial thickness grafts (lamellar), full thickness grafts (penetrating).
Surgery Type
- Conventional Surgery
- Laser-Assisted Surgery
On the basis of surgery type, the market is segmented into conventional surgery and laser-assisted surgery.
Indication
- Fuch's Endothelial Dystrophy
- Infectious Keratitis
- Bullous Keratopathy
- Keratoconus
- Regraft Procedures
- Corneal Scarring
- Corneal Ulcers
- Others
On the basis of indication, the market is segmented into fuch's endothelial dystrophy, infectious keratitis, bullous keratopathy, keratoconus, regraft procedures, corneal scarring, corneal ulcers and others.
Gender
- Female
- Male
On the basis of gender, the market is segmented into female and male.
Age Group
- Geriatric
- Adult
- Pediatric
On the basis of age group, the market is segmented into geriatric, adult and pediatric.
End User
- Hospitals,
- Eye Clinics,
- Ambulatory Surgical Centers,
- Academic & Research Institutes
- Others
On the basis of end user, the market is segmented into hospitals, eye clinics, ambulatory surgical centers, academic & research institutes and others.
Global Corneal Transplant Market Regional Analysis/Insights
Global corneal transplant market is analyzed, and market size insights and trends are provided based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user as referenced above.
The countries covered in this market report are U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Belgium, Denmark, Norway, Sweden, Poland, Rest of Europe, Brazil, Argentina, Rest of South America, China, India, Japan, Australia, South Korea, Singapore, Philippines, Malaysia, Indonesia, Thailand and Rest of Asia-Pacific, South Africa, Saudi Arabia, U.A.E., Egypt, Israel, Rest of Middle East and Africa.
North America is expected to dominate the market due to factors like high prevalence of infections, advanced healthcare infrastructure, strong consumer awareness and purchasing power, ongoing research and development initiatives, established marketing and distribution networks. The U.S. is expected to dominate in the North America market due to factors such as large population, high healthcare expenditure, sophisticated healthcare system, extensive pharmaceutical industry, and widespread consumer awareness. Germany is expected to dominate in the Europe market due to its advanced healthcare infrastructure, significant consumer demand for eye treatments, strong pharmaceutical industry, extensive research and development efforts, and well-established distribution networks. China is expected to dominate in the Asia-Pacific market due to its large population, increasing healthcare spending, expanding pharmaceutical industry, growing consumer awareness, and demand for treatments, coupled with a developing healthcare infrastructure and a rising prevalence.
The country section of the report also provides individual market impacting factors and changes in market regulation that impact the current and future trends of the market. Data points such as down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Corneal Transplant Market Share Analysis
The global corneal transplant market is segmented into eight notable segments based on procedure type, type, donor type, graft type, surgery type, indication, gender, age group, and end user.
The global corneal transplant market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, and application dominance. The above data points provided are only related to the companies' focus on the global corneal transplant market.
Some of the major players operating in the global corneal transplant market are ZEISS Group (Carl Zeiss Meditec AG.), Alcon, CorneaGen, Ziemer Ophthalmic Systems AG, RUMEX International Co., among others.
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE GLOBAL CORNEAL IMPLANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 MULTIVARIATE MODELLING
2.7 MARKET END USER COVERAGE GRID
2.8 DBMR MARKET POSITION GRID
2.9 VENDOR SHARE ANALYSIS
2.1 SECONDARY SOURCES
2.11 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTLE ANALYSIS
4.2 PORTERS FIVE FORCES ANALYSIS
5 GLOBAL CORNEAL TRANSPLANT MARKET: REGULATIONS
5.1 REGULATORY AUTHORITIES IN THE ASIA-PACIFIC REGION
5.2 NORTH AMERICA REGULATORY SCENARIO
5.3 EUROPE REGULATORY SCENARIO
5.4 MIDDLE EAST AND AFRICA REGULATORY SCENARIO
5.5 SOUTH AMERICA REGULATORY SCENARIO
6 CUSTOMIZATION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING PREVALENCE OF EYE DISEASES
7.1.2 RISING GERIATRIC POPULATION
7.1.3 TECHNOLOGICAL ADVANCEMENTS IN CORNEAL IMPLANTS
7.1.4 RISE IN MINIMALLY INVASIVE SURGERY IN CORNEAL TRANSPLANT
7.2 RESTRAINTS
7.2.1 HIGH COST ASSOCIATED WITH CORNEAL TRANSPLANT SURGERY
7.2.2 SHORTAGE OF DONORS IN CORNEAL TRANSPLANT
7.3 OPPORTUNITIES
7.3.1 RISE IN HEALTHCARE INFRASTRUCTURE
7.3.2 INCREASE IN PUBLIC AWARENESS AND EDUCATION
7.3.3 PARTNERSHIPS AND COLLABORATIONS ASSOCIATED WITH CORNEAL TRANSPLANTS
7.4 CHALLENGES
7.4.1 SURGICAL AND POST-SURGICAL COMPLICATIONS
7.4.2 LIMITED AWARENESS AND TRAINING
8 GLOBAL CORNEAL TRANSPLANT MARKET, BY TYPE
8.1 OVERVIEW
8.2 HUMAN CORNEA
8.3 SYNTHETIC
9 GLOBAL CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
9.1 OVERVIEW
9.2 ENDOTHELIAL KERATOPLASTY
9.2.1 DESCEMET'S MEMBRANE ENDOTHELIAL KERATOPLASTY (DMEK)
9.2.2 DESCEMET'S STRIPPING ENDOTHELIAL KERATOPLASTY(DSEK)/DESCEMET'S STRIPPING AUTOMATED ENDOTHELIAL KERATOPLASTY (DSAEK)
9.3 PENETRATING KERATOPLASTY
9.4 ANTERIOR LAMELLAR KERATOPLASTY (ALK)
9.4.1 DEEP ANTERIOR LAMELLAR KERATOPLASTY (DALK)
9.4.2 SUPERFICIAL ANTERIOR LAMELLAR KERATOPLASTY (SALK)
9.5 CORNEAL LIMBAL STEM CELL TRANSPLANT
9.6 ARTIFICIAL CORNEA TRANSPLANT
9.7 OTHERS
10 GLOBAL CORNEAL TRANSPLANT MARKET, BY DONOR TYPE
10.1 OVERVIEW
10.2 ALLOGRAFT
10.3 AUTOGRAFT
11 GLOBAL CORNEAL TRANSPLANT MARKET, BY INDICATION
11.1 OVERVIEW
11.2 FUCH'S ENDOTHELIAL DYSTROPHY
11.3 INFECTIOUS KERATITIS
11.4 BULLOUS KERATOPATHY
11.5 KERATOCONUS
11.6 REGRAFT PROCEDURES
11.7 CORNEAL SCARRING
11.8 CORNEAL ULCERS
11.9 OTHERS
12 GLOBAL CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE
12.1 OVERVIEW
12.2 PARTIAL THICKNESS GRAFTS (LAMELLAR)
12.2.1 DEEP LAMELLAR GRAFTS
12.2.2 SUPERFICIAL LAMELLAR GRAFTS
12.3 FULL THICKNESS GRAFTS (PENETRATING)
13 GLOBAL CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE
13.1 OVERVIEW
13.2 CONVENTIONAL SURGERY
13.3 LASER-ASSISTED SURGERY
14 GLOBAL CORNEAL TRANSPLANT MARKET, BY GENDER
14.1 OVERVIEW
14.2 FEMALE
14.3 MALE
15 GLOBAL CORNEAL TRANSPLANT MARKET, BY AGE GROUP
15.1 OVERVIEW
15.2 GERIATRIC
15.3 ADULT
15.4 PEDIATRIC
16 GLOBAL CORNEAL TRANSPLANT MARKET, BY END USER
16.1 OVERVIEW
16.2 HOSPITALS
16.3 EYE CLINICS
16.4 AMBULATORY SURGICAL CENTERS
16.5 ACADEMIC & RESEARCH INSTITUTES
16.6 OTHERS
17 GLOBAL CORNEAL TRANSPLANT MARKET, BY REGION
17.1 OVERVIEW
17.2 NORTH AMERICA
17.2.1 U.S
17.2.2 CANADA
17.2.3 MEXICO
17.3 EUROPE
17.3.1 GERMANY
17.3.2 FRANCE
17.3.3 UK
17.3.4 SPAIN
17.3.5 ITALY
17.3.6 RUSSIA
17.3.7 SWITZERLAND
17.3.8 NETHERLANDS
17.3.9 TURKEY
17.3.10 BELGIUM
17.3.11 REST OF EUROPE
17.4 ASIA-PACIFIC
17.4.1 CHINA
17.4.2 INDIA
17.4.3 JAPAN
17.4.4 AUSTRALIA
17.4.5 SOUTH KOREA
17.4.6 SINGAPORE
17.4.7 PHILIPPINES
17.4.8 MALAYSIA
17.4.9 INDONESIA
17.4.10 THAILAND
17.4.11 REST OF ASIA-PACIFIC
17.5 SOUTH AMERICA
17.5.1 BRAZIL
17.5.2 ARGENTINA
17.5.3 REST OF SOUTH AMERICA
17.6 MIDDLE EAST AND AFRICA
17.6.1 SOUTH AFRICA
17.6.2 SAUDI ARABIA
17.6.3 U.A.E.
17.6.4 EGYPT
17.6.5 ISRAEL
17.6.6 REST OF MIDDLE EAST AND AFRICA
18 GLOBAL CORNEAL TRANSPLANT MARKET: COMPANY LANDSCAPE
18.1 COMPANY SHARE ANALYSIS: GLOBAL
18.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
18.3 COMPANY SHARE ANALYSIS: EUROPE
18.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
19 SWOT ANALYSIS
20 COMPANY PROFILES
20.1 ZEISS GROUP (CARL ZEISS MEDITEC AG.)
20.1.1 COMPANY SNAPSHOT
20.1.2 REVENUE ANALYSIS
20.1.3 COMPANY SHARE ANALYSIS
20.1.4 PRODUCT PORTFOLIO
20.1.5 RECENT DEVELOPMENTS
20.2 ALCON
20.2.1 COMPANY SNAPSHOT
20.2.2 REVENUE ANALYSIS
20.2.3 COMPANY SHARE ANALYSIS
20.2.4 PRODUCT PORTFOLIO
20.2.5 RECENT DEVELOPMENT
20.3 CORNEAGEN
20.3.1 COMPANY SNAPSHOT
20.3.2 COMPANY SHARE ANALYSIS
20.3.3 PRODUCT PORTFOLIO
20.3.4 RECENT DEVELOPMENT
20.4 ZIEMER OPHTHALMIC SYSTEMS AG
20.4.1 COMPANY SNAPSHOT
20.4.2 COMPANY SHARE ANALYSIS
20.4.3 PRODUCT PORTFOLIO
20.4.4 RECENT DEVELOPMENT
20.5 RUMEX INTERNATIONAL CO.
20.5.1 COMPANY SNAPSHOT
20.5.2 COMPANY SHARE ANALYSIS
20.5.3 PRODUCT PORTFOLIO
20.5.4 RECENT DEVELOPMENT
20.6 AJL OPHTHALMIC S.A.
20.6.1 COMPANY SNAPSHOT
20.6.2 PRODUCT PORTFOLIO
20.6.3 RECENT DEVELOPMENT
20.7 CORNEAT VISION
20.7.1 COMPANY SNAPSHOT
20.7.2 PRODUCT PORTFOLIO
20.7.3 RECENT DEVELOPMENT
20.8 FLORIDA LIONS EYE BANK
20.8.1 COMPANY SNAPSHOT
20.8.2 PRODUCT PORTFOLIO
20.8.3 RECENT DEVELOPMENT
20.9 KERAMED, INC.
20.9.1 COMPANY SNAPSHOT
20.9.2 PRODUCT PORTFOLIO
20.9.3 RECENT DEVELOPMENT
20.1 MASSACHUSETTS EYE AND EAR
20.10.1 COMPANY SNAPSHOT
20.10.2 PRODUCT PORTFOLIO
20.10.3 RECENT DEVELOPMENT
20.11 OCL VISION
20.11.1 COMPANY SNAPSHOT
20.11.2 SERVICE PORTFOLIO
20.11.3 RECENT DEVELOPMENT
20.12 OVATION INTERNATIONAL
20.12.1 COMPANY SNAPSHOT
20.12.2 PRODUCT PORTFOLIO
20.12.3 RECENT DEVELOPMENT
20.13 SAN DIEGO EYE BANK
20.13.1 COMPANY SNAPSHOT
20.13.2 SERVICE PORTFOLIO
20.13.3 RECENT DEVELOPMENT
21 QUESTIONNAIRE
22 RELATED REPORTS
List of Table
TABLE 1 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY SURGERY TYPE
TABLE 2 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY INDICATION
TABLE 3 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY AGE
TABLE 4 NUMBER OF PATIENTS WAITING IN EACH COUNTRY
TABLE 5 NUMBER OF CORNEAL TRANSPLANTS IN EACH COUNTRY, BY DONOR TYPE
TABLE 6 PERCENTAGE OF HOSPITALS IN EACH COUNTRY WHERE CORNEAL TRANSPLANTS ARE PERFORMED (CLINICS OR HOSPITALS).
TABLE 7 AVERAGE COST FOR THE CORNEAL TRANSPLANT (PER/EYE) WITH RESPECT TO THE PROCEDURE TYPE IN ASIA-PACIFIC (INDIA)
TABLE 8 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN EUROPE
TABLE 9 AVERAGE COST FOR THE CORNEAL TRANSPLANT WITH RESPECT TO THE PROCEDURE TYPE IN SOUTH AMERICA
TABLE 10 GLOBAL CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 11 GLOBAL HUMAN CORNEA IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 12 GLOBAL SYNTHETIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 13 GLOBAL CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 14 GLOBAL ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 15 GLOBAL ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 16 GLOBAL PENETRATING KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 17 GLOBAL ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 18 GLOBAL ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 19 GLOBAL CORNEAL LIMBAL STEM CELL TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 20 GLOBAL ARTIFICIAL CORNEA TRANSPLANT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 21 GLOBAL OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 22 GLOBAL CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 23 GLOBAL ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 24 GLOBAL ALLOGRAFT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 25 GLOBAL CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 26 GLOBAL FUCH'S ENDOTHELIAL DYSTROPHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 27 GLOBAL INFECTIOUS KERATITIS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 28 GLOBAL BULLOUS KERATOPATHY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 29 GLOBAL KERATOCONUS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 30 GLOBAL REGRAFT PROCEDURES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 31 GLOBAL CORNEAL SCARRING IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 32 GLOBAL CORNEAL ULCERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 33 GLOBAL OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 34 GLOBAL CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 35 GLOBAL PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 36 GLOBAL PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 37 GLOBAL FULL THICKNESS GRAFTS (PENETRATING) IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 38 GLOBAL CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 39 GLOBAL CONVENTIONAL SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 40 GLOBAL LASER-ASSISTED SURGERY IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 41 GLOBAL CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 42 GLOBAL FEMALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 43 GLOBAL MALE IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 44 GLOBAL CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 45 GLOBAL GERIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 46 GLOBAL ADULT IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 47 GLOBAL PEDIATRIC IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 48 GLOBAL CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 49 GLOBAL HOSPITALS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 50 GLOBAL EYE CLINICS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 51 GLOBAL AMBULATORY SURGICAL CENTERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 52 GLOBAL ACADEMIC & RESEARCH INSTITUTES IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 53 GLOBAL OTHERS IN CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 54 GLOBAL CORNEAL TRANSPLANT MARKET, BY REGION, 2022-2031 (USD THOUSAND)
TABLE 55 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 56 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 57 NORTH AMERICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 58 NORTH AMERICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 59 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 60 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 61 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 62 NORTH AMERICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 63 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 64 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 65 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 66 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 67 NORTH AMERICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 68 U.S. CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 69 U.S. ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 70 U.S. ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 71 U.S. CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 72 U.S. CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 73 U.S. CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 74 U.S. PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 75 U.S. CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 76 U.S. CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 77 U.S. CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 78 U.S. CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 79 U.S. CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 80 CANADA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 81 CANADA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 82 CANADA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 83 CANADA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 84 CANADA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 85 CANADA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 86 CANADA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 87 CANADA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 88 CANADA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 89 CANADA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 90 CANADA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 91 CANADA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 92 MEXICO CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 93 MEXICO ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 94 MEXICO ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 95 MEXICO CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 96 MEXICO CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 97 MEXICO CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 98 MEXICO PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 99 MEXICO CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 100 MEXICO CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 101 MEXICO CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 102 MEXICO CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 103 MEXICO CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 104 EUROPE CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 105 EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 106 EUROPE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 107 EUROPE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 108 EUROPE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 109 EUROPE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 110 EUROPE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 111 EUROPE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 112 EUROPE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 113 EUROPE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 114 EUROPE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 115 EUROPE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 116 EUROPE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 117 GERMANY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 118 GERMANY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 119 GERMANY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 120 GERMANY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 121 GERMANY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 122 GERMANY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 123 GERMANY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 124 GERMANY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 125 GERMANY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 126 GERMANY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 127 GERMANY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 128 GERMANY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 129 FRANCE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 130 FRANCE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 131 FRANCE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 132 FRANCE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 133 FRANCE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 134 FRANCE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 135 FRANCE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 136 FRANCE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 137 FRANCE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 138 FRANCE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 139 FRANCE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 140 FRANCE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 141 UK CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 142 UK ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 143 UK ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 144 UK CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 145 UK CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 146 UK CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 147 UK PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 148 UK CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 149 UK CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 150 UK CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 151 UK CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 152 UK CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 153 SPAIN CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 154 SPAIN ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 155 SPAIN ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 156 SPAIN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 157 SPAIN CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 158 SPAIN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 159 SPAIN PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 160 SPAIN CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 161 SPAIN CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 162 SPAIN CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 163 SPAIN CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 164 SPAIN CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 165 ITALY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 166 ITALY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 167 ITALY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 168 ITALY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 169 ITALY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 170 ITALY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 171 ITALY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 172 ITALY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 173 ITALY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 174 ITALY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 175 ITALY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 176 ITALY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 177 RUSSIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 178 RUSSIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 179 RUSSIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 180 RUSSIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 181 RUSSIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 182 RUSSIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 183 RUSSIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 184 RUSSIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 185 RUSSIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 186 RUSSIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 187 RUSSIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 188 RUSSIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 189 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 190 SWITZERLAND ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 191 SWITZERLAND ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 192 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 193 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 194 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 195 SWITZERLAND PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 196 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 197 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 198 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 199 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 200 SWITZERLAND CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 201 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 202 NETHERLANDS ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 203 NETHERLANDS ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 204 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 205 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 206 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 207 NETHERLANDS PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 208 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 209 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 210 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 211 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 212 NETHERLANDS CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 213 TURKEY CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 214 TURKEY ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 215 TURKEY ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 216 TURKEY CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 217 TURKEY CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 218 TURKEY CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 219 TURKEY PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 220 TURKEY CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 221 TURKEY CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 222 TURKEY CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 223 TURKEY CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 224 TURKEY CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 225 BELGIUM CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 226 BELGIUM ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 227 BELGIUM ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 228 BELGIUM CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 229 BELGIUM CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 230 BELGIUM CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 231 BELGIUM PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 232 BELGIUM CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 233 BELGIUM CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 234 BELGIUM CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 235 BELGIUM CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 236 BELGIUM CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 237 REST OF EUROPE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 238 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 239 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 240 ASIA-PACIFIC ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 241 ASIA-PACIFIC ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 242 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 243 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 244 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 245 ASIA-PACIFIC PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 246 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 247 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 248 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 249 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 250 ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 251 CHINA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 252 CHINA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 253 CHINA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 254 CHINA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 255 CHINA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 256 CHINA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 257 CHINA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 258 CHINA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 259 CHINA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 260 CHINA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 261 CHINA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 262 CHINA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 263 INDIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 264 INDIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 265 INDIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 266 INDIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 267 INDIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 268 INDIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 269 INDIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 270 INDIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 271 INDIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 272 INDIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 273 INDIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 274 INDIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 275 JAPAN CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 276 JAPAN ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 277 JAPAN ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 278 JAPAN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 279 JAPAN CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 280 JAPAN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 281 JAPAN PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 282 JAPAN CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 283 JAPAN CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 284 JAPAN CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 285 JAPAN CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 286 JAPAN CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 287 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 288 AUSTRALIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 289 AUSTRALIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 290 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 291 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 292 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 293 AUSTRALIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 294 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 295 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 296 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 297 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 298 AUSTRALIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 299 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 300 SOUTH KOREA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 301 SOUTH KOREA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 302 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 303 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 304 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 305 SOUTH KOREA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 306 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 307 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 308 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 309 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 310 SOUTH KOREA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 311 SINGAPORE CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 312 SINGAPORE ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 313 SINGAPORE ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 314 SINGAPORE CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 315 SINGAPORE CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 316 SINGAPORE CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 317 SINGAPORE PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 318 SINGAPORE CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 319 SINGAPORE CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 320 SINGAPORE CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 321 SINGAPORE CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 322 SINGAPORE CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 323 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 324 PHILIPPINES ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 325 PHILIPPINES ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 326 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 327 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 328 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 329 PHILIPPINES PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 330 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 331 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 332 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 333 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 334 PHILIPPINES CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 335 MALAYSIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 336 MALAYSIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 337 MALAYSIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 338 MALAYSIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 339 MALAYSIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 340 MALAYSIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 341 MALAYSIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 342 MALAYSIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 343 MALAYSIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 344 MALAYSIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 345 MALAYSIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 346 MALAYSIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 347 INDONESIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 348 INDONESIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 349 INDONESIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 350 INDONESIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 351 INDONESIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 352 INDONESIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 353 INDONESIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 354 INDONESIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 355 INDONESIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 356 INDONESIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 357 INDONESIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 358 INDONESIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 359 THAILAND CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 360 THAILAND ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 361 THAILAND ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 362 THAILAND CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 363 THAILAND CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 364 THAILAND CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 365 THAILAND PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 366 THAILAND CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 367 THAILAND CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 368 THAILAND CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 369 THAILAND CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 370 THAILAND CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 371 REST OF ASIA-PACIFIC CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 372 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 373 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 374 SOUTH AMERICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 375 SOUTH AMERICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 376 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 377 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 378 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 379 SOUTH AMERICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 380 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 381 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 382 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 383 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 384 SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 385 BRAZIL CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 386 BRAZIL ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 387 BRAZIL ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 388 BRAZIL CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 389 BRAZIL CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 390 BRAZIL CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 391 BRAZIL PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 392 BRAZIL CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 393 BRAZIL CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 394 BRAZIL CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 395 BRAZIL CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 396 BRAZIL CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 397 ARGENTINA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 398 ARGENTINA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 399 ARGENTINA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 400 ARGENTINA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 401 ARGENTINA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 402 ARGENTINA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 403 ARGENTINA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 404 ARGENTINA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 405 ARGENTINA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 406 ARGENTINA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 407 ARGENTINA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 408 ARGENTINA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 409 REST OF SOUTH AMERICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 410 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY COUNTRY, 2022-2031 (USD THOUSAND)
TABLE 411 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 412 MIDDLE EAST AND AFRICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 413 MIDDLE EAST AND AFRICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 414 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 415 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 416 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 417 MIDDLE EAST AND AFRICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 418 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 419 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 420 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 421 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 422 MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 423 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 424 SOUTH AFRICA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 425 SOUTH AFRICA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 426 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 427 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 428 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 429 SOUTH AFRICA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 430 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 431 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 432 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 433 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 434 SOUTH AFRICA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 435 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 436 SAUDI ARABIA ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 437 SAUDI ARABIA ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 438 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 439 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 440 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 441 SAUDI ARABIA PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 442 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 443 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 444 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 445 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 446 SAUDI ARABIA CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 447 U.A.E. CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 448 U.A.E. ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 449 U.A.E. ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 450 U.A.E. CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 451 U.A.E. CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 452 U.A.E. CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 453 U.A.E. PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 454 U.A.E. CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 455 U.A.E. CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 456 U.A.E. CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 457 U.A.E. CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 458 U.A.E. CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 459 EGYPT CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 460 EGYPT ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 461 EGYPT ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 462 EGYPT CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 463 EGYPT CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 464 EGYPT CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 465 EGYPT PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 466 EGYPT CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 467 EGYPT CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 468 EGYPT CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 469 EGYPT CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 470 EGYPT CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 471 ISRAEL CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
TABLE 472 ISRAEL ENDOTHELIAL KERATOPLASTY IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 473 ISRAEL ANTERIOR LAMELLAR KERATOPLASTY (ALK) IN CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 474 ISRAEL CORNEAL TRANSPLANT MARKET, BY TYPE, 2022-2031 (USD THOUSAND)
TABLE 475 ISRAEL CORNEAL TRANSPLANT MARKET, BY DONOR TYPE, 2022-2031 (USD THOUSAND)
TABLE 476 ISRAEL CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 477 ISRAEL PARTIAL THICKNESS GRAFTS (LAMELLAR) IN CORNEAL TRANSPLANT MARKET, BY GRAFT TYPE, 2022-2031 (USD THOUSAND)
TABLE 478 ISRAEL CORNEAL TRANSPLANT MARKET, BY SURGERY TYPE, 2022-2031 (USD THOUSAND)
TABLE 479 ISRAEL CORNEAL TRANSPLANT MARKET, BY INDICATION, 2022-2031 (USD THOUSAND)
TABLE 480 ISRAEL CORNEAL TRANSPLANT MARKET, BY GENDER, 2022-2031 (USD THOUSAND)
TABLE 481 ISRAEL CORNEAL TRANSPLANT MARKET, BY AGE GROUP, 2022-2031 (USD THOUSAND)
TABLE 482 ISRAEL CORNEAL TRANSPLANT MARKET, BY END USER, 2022-2031 (USD THOUSAND)
TABLE 483 REST OF MIDDLE EAST AND AFRICA CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE, 2022-2031 (USD THOUSAND)
List of Figure
FIGURE 1 GLOBAL CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 2 GLOBAL CORNEAL TRANSPLANT MARKET: DATA TRIANGULATION
FIGURE 3 GLOBAL CORNEAL TRANSPLANT MARKET: DROC ANALYSIS
FIGURE 4 GLOBAL CORNEAL TRANSPLANT MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 GLOBAL CORNEAL TRANSPLANT MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 GLOBAL CORNEAL TRANSPLANT MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 GLOBAL CORNEAL TRANSPLANT MARKET: MARKET END USER COVERAGE GRID
FIGURE 8 GLOBAL CORNEAL TRANSPLANT MARKET: DBMR MARKET POSITION GRID
FIGURE 9 GLOBAL CORNEAL TRANSPLANT MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 GLOBAL CORNEAL TRANSPLANT MARKET: SEGMENTATION
FIGURE 11 SIX SEGMENTS COMPRISE THE GLOBAL CORNEAL TRANSPLANT MARKET, BY PROCEDURE TYPE
FIGURE 12 EXECUTIVE SUMMARY
FIGURE 13 STRATEGIC DECISIONS
FIGURE 14 INCREASING PREVALENCE OF EYE DISEASES IS DRIVING THE GROWTH OF THE GLOBAL CORNEAL TRANSPLANT MARKET FROM 2024 TO 2031
FIGURE 15 THE ENDOTHELIAL KERATOPLASTY SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL CORNEAL TRANSPLANT MARKET IN 2024 AND 2031
FIGURE 16 NORTH AMERICA IS EXPECTED TO DOMINATE THE GLOBAL CORNEAL TRANSPLANT MARKET, AND ASIA-PACIFIC IS EXPECTED TO GROW WITH THE HIGHEST CAGR IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 17 ASIA-PACIFIC IS THE FASTEST-GROWING REGION FOR GLOBAL CORNEAL TRANSPLANT MARKET MANUFACTURERS IN THE FORECAST PERIOD OF 2024 TO 2031
FIGURE 18 DROC ANALYSIS
FIGURE 19 GLOBAL CORNEAL TRANSPLANT MARKET: BY TYPE, 2023
FIGURE 20 GLOBAL CORNEAL TRANSPLANT MARKET: BY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 21 GLOBAL CORNEAL TRANSPLANT MARKET: TYPE, CAGR (2024-2031)
FIGURE 22 GLOBAL CORNEAL TRANSPLANT MARKET: TYPE, LIFELINE CURVE
FIGURE 23 GLOBAL CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2023
FIGURE 24 GLOBAL CORNEAL TRANSPLANT MARKET: BY PROCEDURE TYPE, 2024-2031 (USD THOUSAND)
FIGURE 25 GLOBAL CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, CAGR (2024-2031)
FIGURE 26 GLOBAL CORNEAL TRANSPLANT MARKET: PROCEDURE TYPE, LIFELINE CURVE
FIGURE 27 GLOBAL CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2023
FIGURE 28 GLOBAL CORNEAL TRANSPLANT MARKET: BY DONOR TYPE, 2024-2031 (USD THOUSAND)
FIGURE 29 GLOBAL CORNEAL TRANSPLANT MARKET: DONOR TYPE, CAGR (2024-2031)
FIGURE 30 GLOBAL CORNEAL TRANSPLANT MARKET: DONOR TYPE, LIFELINE CURVE
FIGURE 31 GLOBAL CORNEAL TRANSPLANT MARKET: BY INDICATION, 2023
FIGURE 32 GLOBAL CORNEAL TRANSPLANT MARKET: BY INDICATION, 2024-2031 (USD THOUSAND)
FIGURE 33 GLOBAL CORNEAL TRANSPLANT MARKET: BY INDICATION, CAGR (2024-2031)
FIGURE 34 GLOBAL CORNEAL TRANSPLANT MARKET: BY INDICATION, LIFELINE CURVE
FIGURE 35 GLOBAL CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2023
FIGURE 36 GLOBAL CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, 2024-2031 (USD THOUSAND)
FIGURE 37 GLOBAL CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, CAGR (2024-2031)
FIGURE 38 GLOBAL CORNEAL TRANSPLANT MARKET: BY GRAFT TYPE, LIFELINE CURVE
FIGURE 39 GLOBAL CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2023
FIGURE 40 GLOBAL CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, 2024-2031 (USD THOUSAND)
FIGURE 41 GLOBAL CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, CAGR (2024-2031)
FIGURE 42 GLOBAL CORNEAL TRANSPLANT MARKET: BY SURGERY TYPE, LIFELINE CURVE
FIGURE 43 GLOBAL CORNEAL TRANSPLANT MARKET: BY GENDER, 2023
FIGURE 44 GLOBAL CORNEAL TRANSPLANT MARKET: BY GENDER, 2024-2031 (USD THOUSAND)
FIGURE 45 GLOBAL CORNEAL TRANSPLANT MARKET: BY GENDER, CAGR (2024-2031)
FIGURE 46 GLOBAL CORNEAL TRANSPLANT MARKET: BY GENDER, LIFELINE CURVE
FIGURE 47 GLOBAL CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2023
FIGURE 48 GLOBAL CORNEAL TRANSPLANT MARKET: BY AGE GROUP, 2024-2031 (USD THOUSAND)
FIGURE 49 GLOBAL CORNEAL TRANSPLANT MARKET: BY AGE GROUP, CAGR (2024-2031)
FIGURE 50 GLOBAL CORNEAL TRANSPLANT MARKET: BY AGE GROUP, LIFELINE CURVE
FIGURE 51 GLOBAL CORNEAL TRANSPLANT MARKET: BY END USER, 2023
FIGURE 52 GLOBAL CORNEAL TRANSPLANT MARKET: BY END USER, 2024-2031 (USD THOUSAND)
FIGURE 53 GLOBAL CORNEAL TRANSPLANT MARKET: BY END USER, CAGR (2024-2031)
FIGURE 54 GLOBAL CORNEAL TRANSPLANT MARKET: BY END USER, LIFELINE CURVE
FIGURE 55 GLOBAL CORNEAL TRANSPLANT MARKET: SNAPSHOT (2023)
FIGURE 56 GLOBAL CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)
FIGURE 57 NORTH AMERICA CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)
FIGURE 58 EUROPE CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)
FIGURE 59 AISA-PACIFIC CORNEAL TRANSPLANT MARKET: COMPANY SHARE 2023 (%)
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
